Update on Risk of Endophthalmitis after Intravitreal Drug Injections and Potential Impact of Elimination of Topical Antibiotics

Documenti analoghi

• The Risk of Endophthalmitis Following Intravitreal Injection in the DRCR.net Laser-Ranibizumab-Triamcinolone Clinical Trials
  di: Bhavsar, Abdhish R., et al.
  Pubblicazione: (2009)
• Intravitreal injections, antibiotics and endophthalmitis
  di: Bhavsar, A R, et al.
  Pubblicazione: (2013)
• The Risk of Endophthalmitis Following Intravitreal Triamcinolone Injection in the DRCRnet and SCORE Clinical Trials
  di: Bhavsar, Abdhish R., et al.
  Pubblicazione: (2007)
• Incidence of endophthalmitis after intravitreal injection of an anti-VEGF agent with or without topical antibiotics
  di: Morioka, Masakazu, et al.
  Pubblicazione: (2020)
• Evaluation of Study Participant Masking of Intravitreal Injections in a Randomized Clinical Trial
  di: Glassman, Adam R., et al.
  Pubblicazione: (2012)